Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 2
2004 5
2005 3
2006 7
2007 8
2008 11
2009 9
2010 9
2011 13
2012 19
2013 13
2014 13
2015 8
2016 9
2017 30
2018 29
2019 35
2020 34
2021 40
2022 31
2023 22
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Results by year

Filters applied: . Clear all
Page 1
Consultation Requests and Satisfaction with a Telehealth Network for Epilepsy: Longitudinal Analysis of the Epilepsy Network Hessen Evaluation.
Zöllner JP, Rosenow F, Schubert-Bast S, Roth C, Knake S, Eickhoff C, Scheuble P, Martin J, Bollensen E, Teepker M, Singer O, Schirmer S, Dietz A, Henn KH, Stolz E, Schüttler-Gahin K, Fischer M, Noda A, Mann C, Strzelczyk A. Zöllner JP, et al. Among authors: dietz a. Telemed J E Health. 2024 Apr 29. doi: 10.1089/tmj.2023.0659. Online ahead of print. Telemed J E Health. 2024. PMID: 38683593
[Update: Epidemiology and Prevention of Oropharyngeal Cancer].
Dietz A, Wichmann G, Wiegand S, Waterboer T, Budach W, Klußmann JP. Dietz A, et al. Laryngorhinootologie. 2024 Apr;103(4):296-313. doi: 10.1055/a-2133-2348. Epub 2024 Apr 2. Laryngorhinootologie. 2024. PMID: 38565110 German.
Liebe Kolleginnen und Kollegen, liebe Freunde der LRO.
Dietz A. Dietz A. Laryngorhinootologie. 2024 Apr;103(4):240-241. doi: 10.1055/a-2255-8026. Epub 2024 Apr 2. Laryngorhinootologie. 2024. PMID: 38565101 German. No abstract available.
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trial.
Brandt A, Schultheiss C, Klinghammer K, Schafhausen P, Busch CJ, Blaurock M, Hinke A, Tometten M, Dietz A, Müller-Richter U, Hahn D, Alt J, Stein A, Binder M. Brandt A, et al. Among authors: dietz a. Front Oncol. 2024 Feb 7;14:1283266. doi: 10.3389/fonc.2024.1283266. eCollection 2024. Front Oncol. 2024. PMID: 38384801 Free PMC article.
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial.
Cavalieri S, Bruno E, Serafini MS, Lenoci D, Canevari S, Lopez-Perez L, Hernandez L, Mariani L, Miceli R, Gavazzi C, Pasanisi P, Rosso E, Cordero F, Bossi P, Golusinski W, Dietz A, Strojan P, Fuereder T, De Cecco L, Licitra L. Cavalieri S, et al. Among authors: dietz a. Front Oncol. 2024 Jan 4;13:1321174. doi: 10.3389/fonc.2023.1321174. eCollection 2023. Front Oncol. 2024. PMID: 38239654 Free PMC article.
315 results